GoodRx Holdings' ROCE trend is concerning. Despite reinvestment in its business, shrinking returns and a significant stock price drop hint at a lack of multi-bagger potential.
RECAP US Stocks Retreat After Rallying in 2023 US stocks pulled back on the first trading day of the year, locking gains posted in 2023, as the Magnificent Seven stocks retreated. A Bloomberg gauge of the seven stocks declined 1.7%, weighing on the S&P 500 and the Nasdaq that are heavily weighted to the tech giants. The$Nasdaq Composite Index(.IXIC.US)$fell 1.6% to close at 14,765.94, its biggest daily decline since October. The$S&P 500 Index(.SPX.US)$slipped 0...
15225861173035898:
bro you n know big heart faith and years of pain only way is up from the bottom love peace harmony goal to buy 3rd world country to save and feed
Concern arises over GoodRx Holdings' high P/S ratio as future revenue projections seem insufficient to maintain positive evaluation. Unless significant revenue improvements occur, high P/S values likely unsustainable.
$GOODRXホールディングス(GDRX.US)$fell Tuesday after raising 13% last week. The drop followed$CVS ヘルス(CVS.US)$investor day. The firm relased 2024 revenue guidance Tuesday morning, announcing a competitive prescription drug product called CostVantage, and a second program called TrueCost.
Stock is near 52 week low. large block purchases are being made on this dip still might have room to be lower. going to take position on the stock due to revenue and brand name. if there is any kind of recession in the near future the stock will be back up to its high due to individuals looking for the best options to pay for their prescriptions. good luck investing 😸
GoodRx's diminishing returns, despite reinvestment, is disheartening. Its sharp stock price drop could indicate investor anticipation of worsening company fundamentals, suggesting other investment options may be more promising.
Pre-Market Stock Movers Gapping up $アドビ(ADBE.US)$ (The stock gained 2.4% before the bell after Morgan Stanley upgraded shares to overweight from equal weight and boosted its price target, citing artificial intelligence tailwinds.) $シェブロン(CVX.US)$ (Shares rose 1.6% after Goldman Sachs upgraded Chevron to buy from neutral and hiked its price target. Analysts said the oil giant is due for a breakout.) $ウォルト・ディズニー(DIS.US)$ (T...
GOODRXホールディングスに関するコメント
📊⚡️📊
US Stocks Retreat After Rallying in 2023
US stocks pulled back on the first trading day of the year, locking gains posted in 2023, as the Magnificent Seven stocks retreated.
A Bloomberg gauge of the seven stocks declined 1.7%, weighing on the S&P 500 and the Nasdaq that are heavily weighted to the tech giants. The $Nasdaq Composite Index(.IXIC.US)$ fell 1.6% to close at 14,765.94, its biggest daily decline since October. The $S&P 500 Index(.SPX.US)$ slipped 0...
good luck investing 😸
Gapping up
$アドビ(ADBE.US)$
(The stock gained 2.4% before the bell after Morgan Stanley upgraded shares to overweight from equal weight and boosted its price target, citing artificial intelligence tailwinds.)
$シェブロン(CVX.US)$
(Shares rose 1.6% after Goldman Sachs upgraded Chevron to buy from neutral and hiked its price target. Analysts said the oil giant is due for a breakout.)
$ウォルト・ディズニー(DIS.US)$
(T...
まだコメントはありません